The company is developing Mydicar as a new first-in-class therapy for patients with chronic heart failure due to systolic dysfunction. The drug uses genetic enzyme replacement therapy to
The trial is being carried out at the Hadassah-Hebrew University Medical Center in Jerusalem, Israel by Dr. Itai Berger, director of Neuro-Cognitive Center, and the principal investigator of
BrainStorm Cell Therapeutics’ new US patent covers the production method of its proprietary stem cells induced to secrete significantly elevated levels of neurotrophic factors for the treatment of
TD-4208 is discovered using the company’s multivalent approach to drug design. The trial will evaluate the bronchodilator effect, safety and tolerability of four doses of TD-4208 and placebo
The partnership, which will include multiple projects over an initial five-year period, will allow the companies to gain deeper, real-world insight about the experience of these patients. As
Under the long-term strategic partnership, Clinipace will be responsible for managing several clinical programs on behalf of Karyopharm in 2014, including oncology, wound healing, and other diseases. KPTI
In 2012, mental health was the second largest US drug class for spending and in 2011, anti-psychotics and antidepressants accounted for $29.2bn in US sales, with over 264
The deal will combine Greenphire’s ClinCard System with ERT’s electronic patient reported outcomes (ePRO) technology. Greenphire vice president of Product Management Kyle Cunningham said by incorporating the company’s
In the trial, about 623 patients were given once-monthly intramuscular injections of aripiprazole lauroxil 441mg, 882mg or placebo for 12 weeks. Patients treated with either 441mg or 882mg
Non-24 is a serious chronic circadian rhythm disorder that affects up to 70 percent of people who are totally blind. The company has launched HETLIOZSolutions to support and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.